Veeco Instruments Inc
VECO Nasdaq Special Industry Machinery, Nec Financials FY2016βFY2025
What Veeco Instruments Inc does
No business description yet.
- Legal name
- VEECO INSTRUMENTS INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001104659-26-019711
0000103145
Revenue and margins
Veeco Instruments Inc had $664M of revenue in fiscal 2025, down 7.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $53.3M in fiscal 2025, 8.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Veeco Instruments Inc returned β to shareholders in fiscal 2025. The diluted share count fell 1.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Veeco Instruments Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $224M | $302M | $305M | $344M | $390M |
| Debt incl. finance leases | $229M | $275M | $275M | $276M | $226M |
| Net debt / EBITDA | 0.1x | β0.3x | β0.3x | β0.7x | β2.9x |
| Debt / equity | 0.5x | 0.5x | 0.4x | 0.4x | 0.3x |
| Interest coverage | 2.0x | 5.2x | 5.9x | 6.1x | 3.9x |
| Current ratio | 2.9x | 2.6x | 3.2x | 4.0x | 4.7x |
| Quick ratio | 2.0x | 1.8x | 2.1x | 2.7x | 3.2x |
| Total assets | $899M | $1.1B | $1.2B | $1.3B | $1.3B |
| Total liabilities | $461M | $550M | $557M | $481M | $440M |
| Shareholders' equity | $438M | $578M | $672M | $771M | $886M |
| Net debt (β = net cash) | $5.5M | β$27.8M | β$30.5M | β$68.1M | β$164M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 3 / 9 | 4 / 9 | 5 / 9 | 6 / 9 | 4 / 9 | 6 / 9 | 6 / 9 | 6 / 9 |
| Accruals ratio | β12.9% | β8.1% | β32.3% | β8.3% | β6.0% | β4.6% | 5.8% | β7.8% | 0.8% | β2.6% |
| Altman Z'' | 5.16 | 2.53 | β1.73 | 0.64 | 1.69 | 1.58 | 2.40 | 2.85 | 3.85 | 4.55 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $332M | $485M | $542M | $419M | $454M | $583M | $646M | $666M | $717M | $664M |
| Gross profit | $133M | $176M | $194M | $158M | $194M | $242M | $263M | $285M | $304M | $265M |
| Research and development | $81.0M | $82.0M | $97.8M | $90.6M | $79.0M | $88.7M | $104M | $113M | $125M | $120M |
| Operating income | β$120M | β$71.9M | β$416M | β$39.6M | $22.6M | $56.7M | $60.3M | $69.9M | $67.0M | $35.7M |
| Interest expense | $0.2M | $19.5M | $21.5M | $22.1M | $24.7M | $28.4M | $11.5M | $11.8M | $11.0M | $9.1M |
| Pretax income | β$119M | β$89.0M | β$434M | β$78.0M | β$8.5M | $25.7M | $51.0M | β$28.3M | $68.8M | $39.4M |
| Income tax | $2.8M | β$37.6M | β$26.7M | $0.8M | β$0.1M | β$0.4M | β$116M | $2.0M | β$4.9M | $4.0M |
| Net income | β$122M | β$51.4M | β$407M | β$78.7M | β$8.4M | $26.0M | $167M | β$30.4M | $73.7M | $35.4M |
| Net income to common | β$122M | β$51.4M | β$407M | β$78.7M | β$8.4M | $26.0M | $167M | β$30.4M | $73.7M | $35.4M |
| Diluted EPS | β$3.10 | β$1.16 | β$8.63 | β$1.66 | β$0.17 | $0.49 | $2.71 | β$0.56 | $1.23 | $0.59 |
| Diluted shares | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B | 0.05B | 0.07B | 0.05B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | β$23.8M | $35.0M | β$37.7M | β$7.4M | $43.0M | $67.7M | $108M | $61.7M | $63.8M | $69.5M |
| Capital expenditure | $11.5M | $24.3M | $12.7M | $10.9M | $6.8M | $40.6M | $24.6M | $27.9M | $18.1M | $16.2M |
| Free cash flow | β$35.3M | $10.7M | β$50.4M | β$18.3M | $36.2M | $27.1M | $83.9M | $33.7M | $45.7M | $53.3M |
| Depreciation and amortization | $32.7M | $50.1M | $50.0M | $34.4M | $30.7M | $26.1M | $25.6M | $25.0M | $25.1M | $20.0M |
| Stock-based compensation | $15.7M | $24.4M | $16.1M | $15.3M | $12.7M | $15.2M | $23.0M | $28.6M | $35.9M | $37.0M |
| Acquisitions | β | $402M | $2.7M | β | β | β | β | $30.4M | β | β |
| Share buybacks | $13.3M | $2.9M | $11.5M | β | β | β | β | β | β | β |
| Dividends and buybacks | $13.3M | $2.9M | $11.5M | β | β | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $344M | $328M | $260M | $245M | $319M | $224M | $302M | $305M | $344M | $390M |
| Total debt | $1.2M | $276M | $287M | $300M | $321M | $229M | $275M | $275M | $276M | $226M |
| Current assets | $502M | $597M | $520M | $476M | $587M | $549M | $669M | $706M | $765M | $845M |
| Current liabilities | $144M | $224M | $160M | $118M | $147M | $189M | $258M | $218M | $192M | $178M |
| Inventory | $77.1M | $120M | $156M | $133M | $146M | $171M | $207M | $238M | $247M | $275M |
| Property and equipment, net | $60.6M | $85.1M | $80.3M | $75.7M | $65.3M | $99.7M | $107M | $118M | $114M | $109M |
| Goodwill | $115M | $307M | $184M | $182M | $182M | $182M | $182M | $215M | $215M | $215M |
| Intangible assets | $58.4M | $370M | $85.1M | $61.5M | $46.2M | $33.9M | $23.9M | $43.9M | $8.8M | $5.7M |
| Total assets | $759M | $1.4B | $901M | $818M | $898M | $899M | $1.1B | $1.2B | $1.3B | $1.3B |
| Total liabilities | $164M | $547M | $463M | $444M | $490M | $461M | $550M | $557M | $481M | $440M |
| Shareholders' equity | $602M | $840M | $438M | $375M | $408M | $438M | $578M | $672M | $771M | $886M |
| Margins | ||||||||||
| Gross margin | 40.0% | 36.4% | 35.7% | 37.7% | 42.8% | 41.5% | 40.7% | 42.8% | 42.4% | 40.0% |
| Operating margin | β36.1% | β14.8% | β76.6% | β9.4% | 5.0% | 9.7% | 9.3% | 10.5% | 9.3% | 5.4% |
| EBITDA margin | β26.3% | β4.5% | β67.4% | β1.2% | 11.7% | 14.2% | 13.3% | 14.2% | 12.8% | 8.4% |
| Net margin | β36.7% | β10.6% | β75.1% | β18.8% | β1.8% | 4.5% | 25.8% | β4.6% | 10.3% | 5.3% |
| FCF margin | β10.6% | 2.2% | β9.3% | β4.4% | 8.0% | 4.6% | 13.0% | 5.1% | 6.4% | 8.0% |
| Returns | ||||||||||
| Return on capital | β36.7% | β7.2% | β70.6% | β7.3% | 4.3% | 12.8% | 11.0% | 8.6% | 9.5% | 4.4% |
| Return on capital employed | β19.5% | β6.2% | β56.1% | β5.7% | 3.0% | 8.0% | 6.9% | 6.9% | 6.3% | 3.1% |
| Return on equity | β20.3% | β7.1% | β63.7% | β19.4% | β2.1% | 6.2% | 32.9% | β4.9% | 10.2% | 4.3% |
| Return on assets | β16.1% | β4.8% | β35.6% | β9.2% | β1.0% | 2.9% | 16.5% | β2.6% | 5.9% | 2.7% |
| Return on tangible equity | β28.5% | β31.5% | β241.8% | β60.1% | β4.7% | 11.7% | 44.9% | β7.3% | 13.5% | 5.3% |
| Growth | ||||||||||
| Revenue growth | β | 45.8% | 11.8% | β22.6% | 8.3% | 28.4% | 10.8% | 3.1% | 7.6% | β7.4% |
| Net income growth | β | β | β | β | β | β | 541.1% | β118.2% | β | β52.0% |
| EPS growth | β | β | β | β | β | β | 453.1% | β120.7% | β | β52.0% |
| FCF growth | β | β | β570.0% | β | β | β25.2% | 209.5% | β59.8% | 35.4% | 16.6% |
| Share count change | β | 12.3% | 6.7% | 0.7% | 1.9% | 10.9% | 22.3% | β18.0% | 14.6% | β1.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | 0.0x | 0.1x | β0.3x | β0.3x | β0.7x | β2.9x |
| Debt / equity | 0.0x | 0.3x | 0.7x | 0.8x | 0.8x | 0.5x | 0.5x | 0.4x | 0.4x | 0.3x |
| Interest coverage | β541.3x | β3.7x | β19.3x | β1.8x | 0.9x | 2.0x | 5.2x | 5.9x | 6.1x | 3.9x |
| Current ratio | 3.5x | 2.7x | 3.2x | 4.0x | 4.0x | 2.9x | 2.6x | 3.2x | 4.0x | 4.7x |
| Quick ratio | 3.0x | 2.1x | 2.3x | 2.9x | 3.0x | 2.0x | 1.8x | 2.1x | 2.7x | 3.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.5% | 5.0% | 2.3% | 2.6% | 1.5% | 7.0% | 3.8% | 4.2% | 2.5% | 2.4% |
| Stock comp / revenue | 4.7% | 5.0% | 3.0% | 3.6% | 2.8% | 2.6% | 3.6% | 4.3% | 5.0% | 5.6% |
| Payouts / FCF | β | 26.8% | β | β | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 3.0 | 4.0 | 5.0 | 6.0 | 4.0 | 6.0 | 6.0 | 6.0 |
| Altman Z'' | 5.2 | 2.5 | β1.7 | 0.6 | 1.7 | 1.6 | 2.4 | 2.8 | 3.8 | 4.6 |
| Accruals ratio | β12.9% | β8.1% | β32.3% | β8.3% | β6.0% | β4.6% | 5.8% | β7.8% | 0.8% | β2.6% |
Source: SEC EDGAR XBRL filings (CIK 0000103145). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.